Amgen Inc. (AMGN) Financial News - S&P 500 Analyst Recommendation Changes for Aug. 17

Amgen Inc. (AMGN)

S&P 500 Analyst Recommendation Changes for Aug. 17

2011-08-17 16:06:24
Quote: 12-Daily Change-2011201120112011 PercentLevel ================================================================================ Wellpoint Inc4.294.244.244.241.2%0.05 JPMorgan Chase & Co4.704.654.654.651.1%0.05 CIGNA Corp3.953.913.913.911.0%0.04 MetroPCS Communications3.973.933.933.931.0%0.04 AT&T Inc4.134.094.034.091.0%0.04 Amgen Inc4.274.234.234.230.9%0.04 Starwood Hotels & Resorts4.274.234.234.230.9%0.04 Time Warner Cable4.284.244.374.370.9%0.04 Host Hotels & Resorts3.713.683.683.680.8%0.03 Medco Health Solutions3.893.863.863.830.8%0.03 Nabors Industries3.973.943.943.940.8%0.03 Broadcom Corp-Cl A4.324.294.244.290.7%0.03 Forest Laboratories3.573.553.553.620.6%0.02 Cliffs Natural Resources4.614.594.594.590.4%0.02 MEMC Electronic Materials3.213.203.203.200.3%0.01 Comcast Corp-Class A4.294.284.284.280.2%0.01 Centurylink Inc4.364.354.354.430.2%0.01 ================================================================================Aug. 17Aug. 16Aug. 15Aug. 12-Daily Change-SOURCE: Bloomberg srose31@bloomberg.net atanzi@bloomberg.net ...
Open whole article (external link)

Other Financial and Stock Market News concerning Amgen Inc.

S&P 500 Analyst Recommendation Changes for Aug. 17 (2011-08-17 16:06:24)
Buy Dividend-Based Stocks During Market Turbulence, RBC Says (2011-08-17 16:06:23)
Navigating Cancer Vaccines' High-Risk/High-Reward Field (2011-08-17 16:06:23)
Analytical Reports on Amgen Inc. and Biogen Idec Inc. - Biotech Companies Look to Promising Future (2011-08-12 01:46:22)
S&P 500 Dividend Health, Forecast Changes for Aug. 11 (2011-08-12 01:46:20)
Traxis Partners Holdings in 2nd Quarter: 13F Alert (2011-08-12 01:46:19)
Stevens Capital Mgmt Holdings in 2nd Quarter: 13F Alert (2011-08-12 01:46:19)
Favorable 1H2011 Biotech M&A Trends (2011-08-12 01:46:18)
FACTBOX-U.S. health and defense industries' lobbying clout (2011-08-12 01:46:18)
Drug and Biotech Stocks to Buy Now (2011-08-10 02:03:13)
AMGEN INC Files SEC form 10-Q, Quarterly Report (2011-08-09 06:03:31)
Kidney foundation chooses new board (2011-08-08 13:52:21)
S&P 500 Dividend Health, Forecast Changes for Aug. 4 (2011-08-05 02:19:18)
Dendreon, Not All Is Lost (2011-08-05 02:19:17)
Buy Buyback-Prone Companies Like IBM, McDonald’s, Citigroup Says (2011-08-05 02:19:16)
InterMune Earnings Cheat Sheet: Streak of Two Straight Quarters of Expanding Margins Snapped (2011-08-05 02:19:14)
Promising Mid- and Large-Cap Dividend Stocks (2011-08-03 04:26:44)
[$$] A Fool's Battle (2011-08-02 04:29:10)
Amgen's CEO Discusses Q2 2011 Results - Earnings Call Transcript (2011-08-01 10:10:41)
S&P 500 Dividend Health, Forecast Changes for Aug. 1 (2011-08-01 10:10:36)
6 Deeply Undervalued Biotech Stocks (2011-07-27 13:17:17)
Betting On Biotech (2011-07-25 03:00:56)
U.S. Stock Options With Biggest Changes in Implied Volatility (2011-07-22 05:21:59)
How Generics And ObamaCare Led To Express Scripts' Mammoth Purchase Of Medco (2011-07-21 12:10:11)
Amgen Ready for a Technical Bounce (2011-07-19 01:56:24)
Johnson and Johnson Second Quarter Earnings Sneak Peek (2011-07-18 02:03:22)
XGEVA® (Denosumab) Granted Marketing Authorization in the European Union (2011-07-18 02:03:20)
Amgen Resolves G-CSF Patent Litigation With Teva (2011-07-18 02:03:18)
S&P 500 Analyst Estimate Revisions for July 14 (2011-07-15 07:08:15)
The Sky's the Limit for Micromet's BiTE Technology (2011-07-15 07:08:11)
S&P 500 Analyst Target Price Changes for July 13 (2011-07-14 04:08:00)
Zalicus: A Potential Target for Pfizer (2011-07-13 09:10:46)
Monday Corporate Bond Brief (2011-07-13 09:10:46)
Micromet signs cancer drug deal with Amgen (2011-07-12 05:56:01)
Micromet deal with Amgen could reap $976 million (2011-07-12 05:56:00)
Amgen’s Space Mice Test Bone-Loss Antibody on Last NASA Shuttle Mission (2011-07-11 06:01:57)
Tuesday Corporate Bond Brief (2011-07-06 07:23:00)
Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss (2011-07-06 07:22:59)
Zalicus Hits Grand Slam With Novartis (2011-07-04 05:28:49)
UPDATE 3-U.S. Medicare proposes change in anemia drug usage (2011-07-04 05:28:47)
UPDATE 1-U.S. Medicare proposes anemia drug coverage change (2011-07-04 05:28:47)
Amgen Sells $3 Billion of Bond to Fund Stock Dividend Payments (2011-06-29 08:16:29)
New Issue-Amgen sells $3 bln debt in three parts (2011-06-29 08:16:26)
Stocks to Watch: Siemens, LinkedIn and More (2011-06-29 08:16:23)
Amgen Inc Earnings Call scheduled for Fri, July 29 (2011-06-24 08:18:17)
Why Amgen Is a Sell and Teva Is a Buy Now (2011-06-23 05:28:27)
Teachers and Schools Across North America Receive $10,000 Amgen Award for Science Teaching Excellence (2011-06-22 10:21:59)
Lazard Capital Managing Director Identifies Top Investments In The Clinical Lab Space; Exclusive interview With Thomas Gallucci (2011-06-21 05:16:44)
A.M. Vitals: Pfizer's Chantix May Increase Risk For Heart Patients (2011-06-20 02:08:47)
Hologic (HOLX) And Qiagen (QGEN) To Cash In On The Physician Office Recovery Thesis According To Piper Jaffray Director; Exclusive Interview With William Quirk (2011-06-20 02:08:46)

Amgen Inc. Stock Summary

Amgen, Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation, and oncology. The company’s principal products include Aranesp and EPOGEN that stimulate the production of red blood cells to treat anemia; Neulasta and NEUPOGEN, which selectively stimulate the production of neutrophils, a type of white blood cell that helps the body fight infections; and ENBREL that blocks the biologic activity of tumor necrosis factor by inhibiting TNF, a substance induced in response to inflam...